INTERNATIONAL PATENT: IMMUNEONCIA THERAPEUTICS, INC., 주식회사 이뮨온시아 FILES APPLICATION FOR "NEOADJUVANT THERAPY USING PD-L1 INHIBITOR FOR TREATING CANCER"

GENEVA, Oct. 19 -- IMMUNEONCIA THERAPEUTICS, INC. (25, Tapsil-ro 35beon-gil,Giheung-gu, Yongin-si,Gyeonggi-do 17084), 주식회사 이뮨온시아 (경기도용인시 기흥구탑실로35번길 25) filed a patent application (PCT/KR2024/004990) for "NEOADJUVANT THERAPY USING PD-L1 INHIBITOR FOR TREATING CANCER" on Apr 13, 2024. With publication no. WO/2025/216346, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s...